CRP and COVID-19: In support of our findings, a recent randomized clinical trial revealed that add-on treatment with atorvastatin in hospitalized COVID-19 patients without prior use of statins led to a significant reduction of CRP levels (Davoodi et al. 2021), indicating this might represent one of the possible anti-inflammatory mechanisms of statin therapy in our patient population.